HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis

Stickel F, Lutz P, Buch S, Fischer J, Rausch V, Silva I, Rosendahl J, Nischalke HD, Krawczyk M, Lammert F, Casper M, Zopf S, Marhenke S, Vogel A, Eyer F, Von Felden J, Gotthardt D, Weiss KH, Spengler U, Mueller S, Canbay A, Baselli GA, Valenti L, Mcquillin A, Berg T, Hampe J, Morgan M (2019)


Publication Type: Conference contribution

Publication year: 2019

Journal

Publisher: ELSEVIER SCIENCE BV

City/Town: AMSTERDAM

Pages Range: E109-E110

Conference Proceedings Title: JOURNAL OF HEPATOLOGY

Event location: Vienna AT

DOI: 10.1016/s0618-8278(19)30195-1

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Stickel, F., Lutz, P., Buch, S., Fischer, J., Rausch, V., Silva, I.,... Morgan, M. (2019). HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis. In JOURNAL OF HEPATOLOGY (pp. E109-E110). Vienna, AT: AMSTERDAM: ELSEVIER SCIENCE BV.

MLA:

Stickel, Felix, et al. "HSD17B13 rs72613567 TA is associated with a reduced risk for developing hepatocellular carcinoma in patients with alcohol-related cirrhosis." Proceedings of the International Liver Congress, Vienna AMSTERDAM: ELSEVIER SCIENCE BV, 2019. E109-E110.

BibTeX: Download